SonaCare Medical, a global leader in minimally invasive high intensity focussed ultrasound (HIFU) technologies, announced early May that it has partnered with University College London (UCL) to create a HIFU Center of Excellence. The Center will provide physician training and proctoring along with clinical studies, 
patient satisfaction research and advanced technology development associated with two innovative HIFU systems: the Sonatherm laparoscopic HIFU surgical ablation system and the Sonablate 500 transrectal HIFU surgical ablation system. According to Mark Emberton, MD, Director of the Division of Surgery and Interventional Science, University College London, “our collaboration with SonaCare Medical’s innovative technology provides a great platform for us to help expand the use of HIFU in a responsible and effective way. Tissue preserving strategies have been used successfully in other solid organ cancers, such as kidney cancer with great results. Published data from our practice continue to demonstrate that focal therapy delivers good cancer control along with a significant reduction in treatment side effects, which suggests a new option in a spectrum of prostate cancer care that, based on risk profile, could effectively balance clinical benefits and quality of life”. “The highly precise Sonablate 500 HIFU transrectal system has already proven an effective way to transition from treating the entire prostate to treating only the known prostate cancer” added Dr Emberton.
Sonacare medical
Charlotte, NC, USA